Nostos Genomics focuses on enhancing genomic insights through its AI-driven variant interpretation platform, specifically aimed at improving rare disease diagnostics. Their new secondary analysis service aims to elevate variant interpretation capabilities, helping institutions tackle complex genetic cases at scale.